NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ibotta, Inc. ("Ibotta" or "the Company") (NYSE:IBTA). Investors who purchased Ibotta securities prior to April 18, 2024, and continue to hold to the present, are encouraged to […]

NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Neogen Corporation ("Neogen" or "the Company") (NASDAQ:NEOG). Investors who purchased Neogen securities prior to January 5, 2025, and continue to hold to the present, are encouraged to obtain additional

NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elevance Health, Inc. ("Elevance" or "the Company") (NYSE:ELV). Investors who purchased Elevance securities prior to April 18, 2024, and continue to hold to the present, are encouraged

NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Flywire Corporation ("Flywire" or "the Company") (NASDAQ:FLYW). Investors who purchased Flywire securities prior to February 28, 2025, and continue to hold to the present, are encouraged to obtain additional

NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lifecore Biomedical, Inc. ("Lifecore" or "the Company") (NASDAQ:LFCR). Investors who purchased Lifecore securities prior to October 7, 2020, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Treace Medical Concepts, Inc. ("Treace Medical" or "the Company") (NASDAQ:TMCI). Investors who purchased Treace Medical securities prior to May 8, 2023, and continue to hold to the present, are

NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Semler Scientific, Inc. ("Semler" or "the Company") (NASDAQ:SMLR). Investors who purchased Semler securities prior to March 10, 2021, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integer Holdings Corporation ("Integer" or "the Company") (NYSE:ITGR). Investors who purchased Integer securities prior to July 25, 2024, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed on behalf of shareholders of Quantum Biopharma Ltd. ("Quantum" or the "Company") (NASDAQ:QNTM).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who

NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICON plc ("ICON" or "the Company") (NASDAQ:ICLR). Investors who purchased ICON securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/ICLR. ICON